# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251014-1480342/1480342_vbtx6.pdf
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price targe...
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $31 to $35.
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target...
B of A Securities analyst Joanna Gajuk maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target fr...
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $...
BrightSpring Health (NASDAQ:BTSG) raises FY2025 sales outlook from $12.00 billion-$12.50 billion to $12.20 billion-$12.60 billi...